PML: The Dark Side of Immunotherapy in Multiple Sclerosis
- PMID: 26497099
- DOI: 10.1016/j.tips.2015.09.006
PML: The Dark Side of Immunotherapy in Multiple Sclerosis
Abstract
Progressive multifocal leukoencephalopathy (PML) is a threat to patients with multiple sclerosis (MS) who undergo treatment with drugs that interfere with normal immune physiology. Here, we summarize PML incidence in MS, risk factors, surveillance strategies, and case definitions to inform neurologists and other clinicians treating patients with immune-mediated diseases.
Keywords: JC virus; PML; natalizumab; risk.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical